Skip to main content

Transfluthrin eave-positioned targeted insecticide (EPTI) reduces human landing rate (HLR) of pyrethroid resistant and susceptible malaria vectors in a semi-field simulated peridomestic space



Volatile pyrethroids (VPs) are proven to reduce human–vector contact for mosquito vectors. With increasing resistance to pyrethroids in mosquitoes, the efficacy of VPs, such as transfluthrin, may be compromised. Therefore, experiments were conducted to determine if the efficacy of transfluthrin eave-positioned targeted insecticide (EPTI) depends on the resistance status of malaria vectors.


Ribbons treated with 5.25 g transfluthrin or untreated controls were used around the eaves of an experimental hut as EPTI inside a semi-field system. Mosquito strains with different levels of pyrethroid resistance were released simultaneously, recaptured by means of human landing catches (HLCs) and monitored for 24-h mortality. Technical-grade (TG) transfluthrin was used, followed by emulsifiable concentrate (EC) transfluthrin and additional mosquito strains. Generalized linear mixed models with binomial distribution were used to determine the impact of transfluthrin and mosquito strain on mosquito landing rates and 24-h mortality.


EPTI treated with 5.25 g of either TG or EC transfluthrin significantly reduced HLR of all susceptible and resistant Anopheles mosquitoes (Odds Ratio (OR) ranging from 0.14 (95% Confidence Interval (CI) [0.11–0.17], P < 0.001) to 0.57, (CI [0.42–0.78] P < 0.001). Both TG and EC EPTI had less impact on landing for the resistant Anopheles arabiensis (Mbita strain) compared to the susceptible Anopheles gambiae (Ifakara strain) (OR 1.50 [95% CI 1.18–1.91] P < 0.001) and (OR 1.67 [95% CI 1.29–2.17] P < 0.001), respectively. The EC EPTI also had less impact on the resistant An. arabiensis (Kingani strain) (OR 2.29 [95% CI 1.78–2.94] P < 0.001) compared to the control however the TG EPTI was equally effective against the resistant Kingani strain and susceptible Ifakara strain (OR 1.03 [95% CI 0.82–1.32] P = 0.75). Finally the EC EPTI was equally effective against the susceptible An. gambiae (Kisumu strain) and the resistant An. gambiae (Kisumu-kdr strain) (OR 0.98 [95% CI 0.74–1.30] P = 0.90).


Transfluthrin-treated EPTI could be useful in areas with pyrethroid-resistant mosquitoes, but it remains unclear whether stronger resistance to pyrethroids will undermine the efficacy of transfluthrin. At this dosage, transfluthrin EPTI cannot be used to kill exposed mosquitoes.


Indoor residual spraying (IRS) and long-lasting insecticidal nets (LLINs) are currently the core mosquito vector control tools employed in national malaria control programmes worldwide [1]. Since 2000, global malaria incidence has decreased by 37% and mortality by 60% [2], to which these tools have contributed approximately 70% of the reduction [1]. However, there are concerns that progress has stagnated  and malaria increased in several countries between 2015 and 2019 [3]. Increased transmission in some areas where elimination was considered to be feasible has also been observed [4, 5]. This increase is likely caused by insufficient coverage and use of core interventions, with fewer than half of households in sub-Saharan Africa owning enough nets for all occupants [3]. Progress may also be impeded by limitations of the core interventions and their effectiveness in certain settings. For example, the current tools do not provide protection in outdoors setting where humans and vectors frequently come into contact before bed time [6]. Furthermore, the development of physiological resistance [7] in mosquito vectors may undermine the continued efficacy of IRS and LLINs [8].

Development of alternative control strategies that cover the existing gaps and that compliment core control tools remains necessary [9]. Proposed measures include spatial repellents (SR) [10, 11], genetically engineered mosquitoes [12], attractive targeted (toxic) sugar bait (ATSB) [13] and endectocides, such as ivermectin [14]. The focus of this study is SR from the pyrethroid class often referred to as volatile pyrethroids (VPs). Volatile pyrethroids vaporize at room temperature and are dispersed into the surrounding area with the aim of creating a bite-free space [15], and they can be used indoors and outdoors. Previous studies have demonstrated that VPs, such as transfluthrin and metofluthrin, are effective at reducing the human landing rate (HLR) for a range of mosquitoes [16]. Passive emanators treated with transfluthrin or metofluthrin consistently demonstrated personal protective efficacy exceeding 50% in studies conducted in Cambodia [17], Tanzania [18], Belize [19] and Indonesia [20]. Transfluthrin applied to hessian strips as eave-positioned targeted insecticide (EPTI) has provided over 68% reduction in human vector contact in semi-field studies [10, 21] and over 80% in field studies in Tanzania [10, 11]. Volatile pyrethroids exhibit a dose response, with lower concentrations eliciting behavioural effects that include deterrence, excito-repellency and blood-feeding inhibition [22] and with higher concentrations or longer exposure times increasing knockdown and mortality [23].

Pyrethroid have been the main class of insecticide used in LLINs and IRS [24]. Resistance to these insecticides is now widespread [25], which poses a threat not only to the efficacy of LLINs and IRS but potentially also to VPs. Furthermore, effective, long-lasting volatile insecticides of chemical classes other than pyrethroids are not yet available for public health use [26]. It is necessary to know whether the efficacy of VPs may be compromised by pyrethroid resistance and, therefore, if VPs can be used in areas with existing pyrethroid-resistant mosquito populations. VPs are from the same chemical class, which would normally indicate cross-resistance; however, structural differences between transfluthrin and non-volatile pyrethroid indicate that cross-resistance may not occur [27]. Therefore, the objectives of this study were to determine (1) the efficacy of transfluthrin applied as EPTI to reduce HLR of multiple strains of Afrotropical malaria vectors with varying levels of pyrethroid resistance and (2) delayed mortality induced by EPTI exposure.


Study site

The experiment was conducted in a semi-field system (SFS) located in Bagamoyo, Tanzania, from March 2018 to October 2018 and from August 2019 to September 2019. The SFS measures 21 × 29 × 4.5 m and is divided into three compartments. Two heavy-duty polyethylene walls separate these compartments, preventing air movement between the chambers and reducing the chance of cross-contamination when working with VPs or other aerosols. The SFS allows for controlled experiments with disease-free mosquitoes to be conducted under field like climatic conditions [28]. In each compartment, an experimental hut [29] was constructed, and tests were conducted outside the huts to simulate a peridomestic space.

Study mosquitoes

Five laboratory-reared mosquito strains were used in these experiments: (1) pyrethroid-susceptible Anopheles gambiae sensu stricto (s.s.) (Kisumu strain) and (2) pyrethroid-resistant An. gambiae s.s. (Kisumu-kdr strain) with L1014S kdr, i.e., kdr-east resistance mechanism [30], both originating from Kisumu, Kenya; (3) pyrethroid-susceptible An. gambiae s.s. (Ifakara strain) originating from Ifakara, Tanzania, and in colony at IHI since 1996; (4) pyrethroid-resistant Anopheles arabiensis (Mbita strain) from the International Centre of Insect Physiology and Ecology (ICIPE), Kisumu, Kenya, expressing a moderate level of phenotypical resistance against permethrin and deltamethrin (the mechanism is likely metabolic but not confirmed); and (5) An. arabiensis (Kingani strain) originating from Ifakara and in colony at Bagamoyo since 2015, expressing a high level of phenotypical resistance against permethrin and deltamethrin [31]. The two An. arabiensis strains have been tested and found to be free of kdr mutations (L1014F kdr-west and L1014S kdr-east) (unpublished data) commonly associated with pyrethroid resistance. It is likely that the metabolic resistance mechanism was responsible for their survival in the presence pyrethroid insecticides.

Before the start of semi-field experiments, susceptibility tests were conducted for each mosquito strain using tube test bioassays performed following World Health Organization (WHO) guidelines [32]. Non-blood-fed 3- to 5-day-old mosquitoes were exposed to insecticide-impregnated papers at the standard WHO discriminating dose for the pyrethroids permethrin (0.75%) and deltamethrin (0.05%). These insecticides were selected because they belong to the same chemical class as transfluthrin and are commonly used on LLINs.

All mosquito strains are maintained at the Bagamoyo branch of the Ifakara Health Institute (IHI) according to MR4 guidelines [33]. Larvae are fed on fish food (TetraMin® tropical flakes) and adult mosquitoes on 10% sucrose ad libitum. Bovine blood meals are provided to adult females for egg production using membrane-feeding assay. The insectary is maintained at 27 ± 5 °C and 70–100% relative humidity with approximately 12:12 light:dark (ambient lighting).

The experiments used 3- to 8-day-old female mosquitoes that had never blood-fed. The mosquitoes were sugar starved for 6 h prior to the experiment. Because more than one mosquito strain with the same morphology was released simultaneously, red and yellow fluorescent pigments (Swada, Cheshire, UK) were used to differentiate between strains. Mosquitoes were marked in a cup by dusting the mesh lid of the cup with a brush containing the colour pigment; thereby creating a cloud of pigment that was transferred to the mosquitoes in small amounts. Preliminary experiments indicated that the fluorescent pigments did not influence mosquito responses, feeding behaviours or survival. Also the same fluorescent has been used in the marking and recapture experiment without altering the behaviour of the coloured mosquitoes [34].

Preparation of transfluthrin eave-positioned targeted insecticide (EPTI)

Hessian material has proved very useful for the delivery of transfluthrin because it has a much slower release rate than other textiles and thus increases the longevity of the VP devices [21, 35, 36]. Hessian sacks were purchased locally, washed using well water and powder detergent (OMO®, Unilever, Nairobi, Kenya), dried under direct sunlight and then cut into 21 m × 10 cm strips. The hessian was treated with either TG or EC transfluthrin formulations (Bayothrin EC, Bayer AG, Monheim am Rhein, Germany). The experiments were initially conducted using TG transfluthrin emulsified with 100 ml of Tween®20 (Sigma-Aldrich, CAS #9005-64-5). Bayer developed and introduced EC transfluthrin that was used for further experiments. In all experiments, with either formulation, 5.25 g of transfluthrin was impregnated into hessian equivalent to 2.5 g/m2. Drying took place out of direct sunlight to protect the transfluthrin from photolysis by exposure to ultraviolet light [27, 37]. For the control arms, the strips were prepared in the same manner as the treated strips but with only water. During the day, the treated hessian was kept out of direct sunlight at the ambient outdoor temperature (24–27.6 °C) on a metal frame.

Experimental procedure

The primary aim of the study was to determine if pyrethroid resistance in mosquitoes has a negative impact on the efficacy of transfluthrin EPTI. To do this, the treated hessian was placed on the eaves gaps of experimental huts located in the SFS, out of direct sunlight (Fig. 1a). Applying insecticide in this targeted way exploits the natural movement of air rising inside houses and being funnelled out through the eaves, over the treated hessian and into the peridomestic space, helping to disperse insecticide.

Fig. 1

The evaluation of transfluthrin EPTI in the semi-field system. a Yellowish strips represent transfluthrin hessian strip position on the eave “EPTI”. b A volunteer sitting outside the experiment hut conducting HLC. c The schematic representation of the experiment inside a compartment of the semi-field system

Human landing catch (HLC) were conducted 2 m outside the experimental hut (Fig. 1b, c) to mimic the peridomestic environment. Mosquitoes were released outside the experimental hut at every corner of the SFS compartment, eliminating directional bias in their approach to the human volunteer. Three separate experiments were conducted to evaluate the efficacy of (1) TG transfluthrin EPTI against Ifakara strain, Mbita strain and Kingani strain mosquitoes; (2) EC transfluthrin EPTI against Ifakara strain, Mbita strain and Kingani strain mosquitoes; and (3) EC transfluthrin EPTI against Kisumu strain and Kisumu-kdr strain mosquitoes.

During each experiment, either transfluthrin EPTI or the control (water-treated hessian) was assigned to one of two separate compartments of the SFS. The treatments remained fixed for a block of four days, after which they were rotated. HLC volunteers rotated between compartments daily. Four volunteers were recruited but only two used each day. The experiment was conducted for 4 blocks over 16 days, after which each volunteer conducted HLC for each treatment 4 times in each compartment. The volunteers were rotated to control for any bias caused by individual attractiveness to mosquitoes [25]. Prior to the start of the experiment, for acclimatization, mosquitoes were transferred from the insectary to the middle compartment of the SFS 30–45 min before their release.

Each day 80 mosquitoes of each strain were introduced into each compartment. Mosquitoes were separated into batches of 20 per strain and placed into 4 release cages, one in each corner of each compartment. The mosquitoes were released remotely by gently pulling strings connecting the release cages to simulate mosquitoes approaching the peridomestic space from multiple directions.

Throughout the experiment, volunteers wore shorts, covered shoes, and bug jackets to standardize the area available for mosquito landings. Mosquitoes that landed on the area between the ankle and the knee were collected using mouth aspirators through HLC (Fig. 1b). Mosquitoes were recaptured continuously for 50 min every hour for 4 consecutive hours between 18:30 and 22:30 h. Each hour, a new collection cup was used and labelled with the time and date. These mosquitoes were transferred to the insectary after 4 h, supplied with 10% sucrose and held for 24 h to observe 24-h mortality.

Sample size

Sample-size calculations were performed using simulation-based power analysis [25] in R statistical software version 3.02 ( with a significance level of 0.05 for rejecting the null hypothesis. Data analysis for experimental data was planned to be conducted using generalized linear mixed models (GLMMs) [38]. Therefore, 1000 simulations of GLMMs approximating those used to analyse project data were run using a 2 × 2 Latin square design with volunteers rotating nightly. The power to predict the difference in mosquito landings between control and treatment was estimated as the proportion of the 1000 simulated data sets in which the null hypothesis was rejected when the GLMM was run. The simulations indicated that with an estimated 80 mosquitoes released per compartment per night and 60% recapture of released mosquitoes, there was 100% chance of detecting a 50% reduction in mosquito landings in the treatment arm after 16 nights of experimentation. Inter-observational variance among daily experiments was set at 5%, and variability between times based on previous experiments was set at 25%.

Data analysis

Data were recorded on paper forms and double entered into Microsoft Excel. Cleaning and analysis were done in Stata 13 (StataCorp). For the WHO insecticide susceptibility tests, data were summarized as mean percentage (%) 24-h mortality of the four replicates and reported with 95% confidence intervals.

Data for each experiment using each transfluthrin formulation (EC or TG) were analysed separately (Additional files 1, 2 and 3). For the analysis of the data on the effect of TG transfluthrin EPTI against Ifakara strain, Mbita strain and Kingani strain mosquitoes the additional file 1 was used whereas for the EC EPTI against Ifakara strain, Mbita strain and Kingani strain the additional file 2 was used and the additional file 3 was used for the analysis on the effect of EC EPTI against Kisumu susceptible and KDr strains.

The relative effect of transfluthrin on HLR and 24-h mortality for different mosquito strains was investigated using GLMM with binomial distribution. For HLR, the dependent variable was the proportion of released mosquitoes that were recaptured. For mortality, the dependent variable was the recaptured proportion that died. Treatment, mosquito strain, compartment and volunteer were included as fixed categorical variables, with day included as a random effect. An interaction term between mosquito strain and treatment was included to determine if the effect of treatment varied between mosquito strains.

The protective efficacies of the transfluthrin EPTI against each mosquito strain were calculated as

$${\text{Protective}}\;{\text{efficacy}}\left( {{\text{PE}}} \right) = \left[ {\left( {{\text{C}}{-}{\text{T}}} \right)/{\text{C}}} \right] \times 100\% ,$$

where C stands for the number of mosquitoes landing in the control and T for the number of mosquitoes landing in the treatment. The PE was calculated for each day, and the mean proportion of mosquitoes landing was reported with 95% confidence intervals (CI). For 24-h mortality, the control-corrected mortality was calculated using Abbott’s formula [39]:

$${\text{Control}}\;{\text{Corrected}}\;{\text{mortality}} = \left( {{\text{T}}{-}{\text{C}}} \right)/\left( {1{-}{\text{C}}} \right) \times 100\% ,$$

where C and T represents percentage mortality among mosquitoes landing in the control and treatment, respectively. The control-corrected mortality was calculated for each day, and the mean percentage dead was reported with 95% CI.


WHO insecticide susceptibility tests

The susceptibility status of each mosquito strain to permethrin and deltamethrin is presented in Table 1. Anopheles gambiae Ifakara and Kisumu susceptible strains were fully susceptible. Anopheles arabiensis (Kingani) and An. arabiensis (Mbita) strains were resistant to pyrethroids while An. gambiae kdr was resistant to only permethrin.

Table 1 KD and 24-h mortality of the malaria vectors tested during the WHO insecticide susceptibility test

The efficacy of the transfluthrin EPTI against different mosquito strains

In experiment 1 with TG transfluthrin, a significant interaction between strain and treatment was observed. This indicated that the effect of the transfluthrin EPTI varied between strains under investigation (P < 0.001; Table 2). The use of TG transfluthrin EPTI significantly reduced the odds of landing of pyrethroid-susceptible An. gambiae (Ifakara strain; OR = 0.22 [0.18–0.26], P < 0.001) and had a similar impact on the landing of highly pyrethroid-resistant An. arabiensis (Kingani; OR = 0.23 [0.19–0.27], P < 0.001; Table 3). However, while the TG transfluthrin EPTI reduced the landing of pyrethroid-resistant An. arabiensis (Mbita), it did so to a lesser extent (OR = 0.33 [0.28–0.39], P < 0.001; Table 3). When assessing the efficacy of the EPTI using PE, the PE was similar for susceptible Ifakara 46.2% (95% CI 45.6–65.5), moderately resistant Mbita 46.4% (95% CI 37.9–54.9) and the highly resistant Kingani strain 54.9% (95% CI 41.6–64.1; Table 3). The binomial GLMM for TG transfluthrin indicated that both volunteers 3 and 4 and compartment significantly influenced HLR (in both cases, P < 0.05; Table 2).

Table 2 Generalised linear model output estimating the effect of EC/TG transfluthrin and mosquito strain on human landing rate in the semi-field system, Bagamoyo, Tanzania
Table 3 The adjusted odds ratio of mosquito landings and protective efficacy offered by EC and TG transfluthrin in the semi-field system, Bagamoyo, Tanzania

In experiment 2, using EC transfluthrin EPTI, there was again a significant interaction between strain and treatment, although a different trend was observed (Table 2). As with TG, the EC transfluthrin EPTI was observed to reduce the odds of landing of susceptible An. gambiae (Ifakara strain; OR = 0.17 [0.14–0.20], P < 0.001) and pyrethroid-resistant An. arabiensis (Mbita; OR = 0.23 [0.19–0.27], P < 0.001). However, EC transfluthrin showed lower efficacy against An. arabiensis (Kingani; OR = 0.57 [0.42–0.78], P < 0.001; Table 3). The model also indicated that compartment significantly influenced HLR of the mosquitoes (OR = 0.79 [0.71–0.87], P < 0.001). None of the volunteers influenced HLR (P > 0.05; Table 2).

Finally, in the analysis of the data from experiment 3, the interaction was not significant with Kisumu susceptible and kdr strains, indicating that the transfluthrin EPTI reduced landings of the two mosquitoes species in the same way (Table 2). The odds of landing of Kisumu susceptible and Kisumu kdr were equally reduced (OR = 0.14 [0.11–0.17], P > 0.001; Table 3). During the experiments, the average temperature was 27.8 °C (23.8–31.5 °C) and average relative humidity (RH) was 76.5% (63.6–92%).

Effect of species on HLR in the control

The effects of mosquito species on HLR were examined in the control. The two species colonized from wild mosquitoes in Ifakara, Tanzania, were compared. In both experiments, consistently higher catches were observed with the Ifakara strain than with the Kingani strain. For example, in experiment 2, An. gambiae s.s. (Ifakara) showed a higher landing proportion, with an average of 76.6% (95% CI 70.3–82.9) recapture, than did An. arabiensis (Kingani), with an average of 60.5% (95% CI 56.6–64.4) recapture, and this difference was significant (OR = 0.5 [95% CI 0.4–0.6], P < 0.001; Table 4).

Table 4 The adjusted odds ratio of mosquito landings and protective efficacy offered by EC and TG transfluthrin in the semi-field system, Bagamoyo, Tanzania

Comparison of 24-h mortality induced by transfluthrin-treated eave ribbon between mosquito strains

At 5.25 g dosage, no significant difference in 24-h mortality was observed in the presence of transfluthrin EPTI compared to the control across all mosquitoes strains (P > 0.05).


The efficacy of EPTI to reduce HLR of malaria vectors

This study was conducted to determine if pyrethroid resistance in mosquitoes would have a negative impact on the efficacy of transfluthrin EPTI. Findings showed that An. arabiensis Kingani strain mosquitoes expressing high phenotypical resistance to pyrethroids were less repelled than the moderately resistant Mbita strain when using EC transfluthrin. However, Kingani, Mbita and Ifakara strains were equally repelled when using TG transfluthrin. It is, therefore, unclear how the different levels of metabolic resistance affect the efficacy of transfluthrin EPTI. TG was less effective against Mbita than against the susceptible Ifakara strain (An. gambiae), while EC was less effective against both the Mbita and the Kingani strains (An. arabiensis). This may indicate that metabolic resistance is indeed detrimental to the efficacy of transfluthrin; however, it is important to be cautioned when comparing species that have different levels of human biting preference (An. gambiae, An. arabiensis) because it is unknown how this variation affects the efficacy of transfluthrin. This study used An. gambiae s.s. as a reference strain because colonization of the susceptible An. arabiensis strain was not possible due to widespread resistance.

This results suggest that kdr target site mutations do not reduce the efficacy of transfluthrin. However, this finding must be interpreted with caution because the susceptibility test of the mosquitoes used revealed low levels of phenotypic resistance. What is clear from this study is that, compared to the control, transfluthrin EPTI can reduce landings of resistant mosquitoes. These findings corroborate previous experiments conducted under field settings in Kilombero Valley, Tanzania [10, 11, 40], in which transfluthrin applied to hessian in eaves (at concentrations higher than 5.25 g) significantly reduced HLR by over 80% and as well in the SFS, where the PE was over 68% [41]. Andres et al. observed that transfluthrin-treated polyester strips provide significant protection in the semi-field using one species of mosquito that was moderately resistant to pyrethroid [41]. Furthermore, transfluthrin-treated eave ribbon provided protection in Kilombero Valley, where malaria transmission is transmitted by An. arabiensis and Anopheles funestus [42], which were confirmed to be highly resistant to pyrethroid [31].

Methodologies used by these previous experiments were not designed to directly compare the differences in HLR between pyrethroid-susceptible and resistant mosquitoes. This study, however, provides a unique opportunity to compare the efficacy of transfluthrin applied as EPTI across different mosquito strains expressing different types and levels of insecticide resistance. Much more work is needed in this area, looking at a wider range of mosquito strains and resistance mechanisms.

It is known that the structural differences between VPs such as transfluthrin, which contain tetrafluorobenzyl alcohol, and non-VPs, such as permethrin, which contain phenoxybenzyl alcohol, may explain the efficacy of transfluthrin against resistant mosquitoes [43]. Horstmann et al. observed that the enzyme responsible for detoxification of non-VPs is unable to bind to the tetrafluorobenzyl moiety of VPs, leaving them active against resistant mosquitoes [27]. Further work is needed to determine the mechanism that causes mosquitoes to be repelled by transfluthrin in order to ascertain whether cross-resistance is possible. On the other hand, combining multiple active ingredients in targeted eave applications may help to combat resistant mosquitoes. Strategies could also combine an SR with a chemical that has high-contact toxicity and thus kills those mosquitoes that are not repelled and that are attempting to enter through the eaves. It was observed that mosquitoes attempting to enter houses spend 80% of their time within 30 cm of the eave [44]; thus, adding a second AI may enhance the control of resistant vectors. As has been observed in one study where the addition of the synergist piperonyl butoxide (PBO) can enhance knockdown by mosquito coils treated with a VP [45].

Despite a reduction of the HRL due to EPTI, inconsistent findings were observed when using PE for measuring efficacy compared to the OR estimates from the model. Such difference may be explained by the fact that OR from the GLMM contains additional explanatory variables that are not considered when using the basic formula for PE calculation. It is, therefore, suggested that for the evaluation of spatial repellent in the semi-field system, GLMM estimates should be presented rather than the calculated PE. The GLMM estimates are more robust as they account for other variables.

The effect of transfluthrin formulation on HLR

While the EC and TG formulations were not compared directly, the EC did produce higher reductions in HLR. This could be explained by formulation differences that may have resulted in higher release rates and thus in different amounts of transfluthrin available in the air. It is known that differential concentrations of transfluthrin will induce different behaviours, including avoidance, irritancy, knockdown and mortality [46]. This dosage-dependent difference in mosquito behavioural response is also observed in other pyrethroid insecticides, including deltamethrin, cyphenothrin, d‐tetramethrin and tetramethrin [47]. The practical advantage of using EC was that it readily dissolves in water, making it more convenient to use, whereas TG transfluthrin required emulsification with detergent to mix with water. Further investigation into transfluthrin formulations is needed to fully assess their efficacy.

The influence of species and strain on HLR

In addition to resistance, HLR was likely to be influenced by other factors (Fig. 2). In the absence of transfluthrin, this study observed differences in landing for the two different mosquito species. The Ifakara strain (An. gambiae) had a higher proportion of landing than did the Kingani strain (An. arabiensis) or the Mbita strain (An. arabiensis). Despite having been colonized for more than 10 years on particular Ifakara and Kingani strains, these mosquitoes demonstrated a behaviour seen in wild mosquitoes. Gilles et al. conducted an experiment in the field where they observed that An. gambiae s.s. were more likely than An. arabiensis strains to land on the person conducting HLC, indicating that species differences influence mosquito landing [48, 49]. The differences in landing between these mosquito species is caused by differences in attraction to human cues [48]. Anopheles arabiensis feed on both human and animals [50] depending on the relative abundance [51] or availability [52] of humans and animals, whereas An. gambiae s.s. feed exclusively on humans [53]. It is, therefore, suggested that the anthropophilic behaviour of An. gambiae s.s. may influence landing of these mosquitoes compared to the more opportunistic An. arabiensis.

Fig. 2

Factors shown to influence HLR and thus the protective efficacy of the EPTI

Furthermore, the response of different species to VPs is well documented, with higher doses of transfluthrin needed to elicit escape responses in robust species such as Aedes aegypti than in Anopheles mosquitoes [46] and with different responses of members of the Anopheles minimus complex to pyrethroids and DDT [54]. It is also known that species vary in their sensitivity to topical repellents [55]. Therefore, in evaluating the efficacy of volatile pyrethroids, it is important to investigate the species and strains that will ultimately be targeted.

The difference in behavioural response of mosquitoes in the presence of repellent may also be associated with age. Studies have demonstrated that younger mosquitoes showed lower response to topical mosquito repellents [56], with very old mosquitoes being more responsive to repellents [57]. This study followed WHO guidance, using younger mosquitoes that are less likely to be affected by pyrethroid exposure [58]. Because the use of young mosquitoes may underestimate the PE of the VP, it is therefore recommended that further work be carried out on the optimal physiological age of mosquitoes to be used in studies of VP.

24-h mortality of malaria vectors after exposure to transfluthrin

The transfluthrin dose used in this study did not induce mortality for any of the mosquito strains; therefore, it was not possible to determine if there was cross-resistance between traditional pyrethroids and transfluthrin. Exposure to doses above 5.25 g of transfluthrin and long exposure have been associated with increased mortality in exposed mosquitoes [22, 59], so these higher doses would be required to determine if there is any difference between resistant and susceptible strains. Only those mosquitoes that were recaptured by HLC were examined for 24-h mortality; therefore, the full impact of transfluthrin on mortality cannot be measured. It is possible that those that did not land may have received a higher and potentially more lethal dose of transfluthrin. While it is useful to know if a mosquito will survive after a bite (and thus potentially go on to transmit disease), a better picture of the efficacy of VPs would be achieved if all mosquitoes were accounted for.

Study limitation

This study has several limitations; firstly, currently, the CDC and WHO susceptibility bioassay do not have a recommended discriminating dose for testing transfluthrin in any mosquito species. Therefore, the resistance status of the mosquito colony was measured for traditional pyrethroids but not for transfluthrin. As transfluthrin has a different chemical structure there may be different mechanisms for resistance [27]. Therefore, future studies such as [60] are recommended to determine the discriminating dose of transfluthrin. Secondly, this study used only laboratory-reared mosquitoes, these mosquitoes may not represent the field mosquitoes and resistance mechanisms that may react differently to the transfluthrin spatial repellent. While field studies with transfluthrin eave-ribbons have shown that they can be effective in areas of insecticide resistance [40], further work is recommended in different settings with different resistance mechanisms and species. Thirdly, the experiment was conducted on susceptible and resistant mosquitoes from different species. It would have been advantageous to have susceptible and resistant mosquitoes of the same species to allow better approximation of the impact of resistance on resistant strains as the level of anthropophily of the different strains clearly influenced the results. Fourthly, in the semi field system, the wind was not detected. Under field conditions airflow (wind) might influence the efficacy of the push–pull system.


Transfluthrin EPTI offered protection against all mosquito species regardless of the mosquitoes’ level of resistance. However, the differences in effect observed in different mosquitoes species highlight the fact that resistance in mosquitoes may be detrimental to the efficacy of transfluthrin. These findings demonstrated that transfluthrin-treated EPTI could be used to control malaria in areas with pyrethroid-resistant mosquitoes. This is particularly important in areas where transfluthrin will be considered for the control of mosquito vectors [20]. Although this study suggests that EPTI reduces HLR for both mosquitoes, additional evidence is needed to determine whether transfluthrin is effective against resistant mosquitoes and other species, such as An. funestus, where it is the dominant vector.

Availability of data and materials

Data generated and analysed for this study are included in this article and its Additional files 1, 2 and 3.


  1. 1.

    Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Cibulskis RE, Alonso P, Aponte J, Aregawi M, Barrette A, Bergeron L, et al. Malaria: global progress 2000–2015 and future challenges. Infect Dis Poverty. 2016;5:61.

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    WHO. World malaria report. Geneva: World Health Organization; 2020.

    Google Scholar 

  4. 4.

    Temu EA, Maxwell C, Munyekenye G, Howard AF, Munga S, Avicor SW, et al. Pyrethroid resistance in Anopheles gambiae, in Bomi County, Liberia, compromises malaria vector control. PLoS ONE. 2012;7:e44986.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Reddy MR, Overgaard HJ, Abaga S, Reddy VP, Caccone A, Kiszewski AE, et al. Outdoor host seeking behaviour of Anopheles gambiae mosquitoes following initiation of malaria vector control on Bioko Island, Equatorial Guinea. Malar J. 2011;10:184.

    PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Monroe A, Moore S, Koenker H, Lynch M, Ricotta E. Measuring and characterizing night time human behaviour as it relates to residual malaria transmission in sub-Saharan Africa: a review of the published literature. Malar J. 2019;18:6.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Hancock PA, Wiebe A, Gleave KA, Bhatt S, Cameron E, Trett A, et al. Associated patterns of insecticide resistance in field populations of malaria vectors across Africa. Proc Natl Acad Sci USA. 2018;115:5938–43.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Sougoufara S, Doucouré S, Backé Sembéne PM, Harry M, Sokhna C. Challenges for malaria vector control in sub-Saharan Africa: resistance and behavioral adaptations in Anopheles populations. J Vector Borne Dis. 2017;54:4–15.

    PubMed  Google Scholar 

  9. 9.

    Sougoufara S, Ottih EC, Tripet F. The need for new vector control approaches targeting outdoor biting Anopheline malaria vector communities. Parasites Vectors. 2020;13:295.

    PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Ogoma SB, Mmando AS, Swai JK, Horstmann S, Malone D, Killeen GF. A low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria. PLoS Negl Trop Dis. 2017;11:e0005455.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  11. 11.

    Masalu JP, Finda M, Okumu FO, Minja EG, Mmbando AS, Sikulu-Lord MT, et al. Efficacy and user acceptability of transfluthrin-treated sisal and hessian decorations for protecting against mosquito bites in outdoor bars. Parasites Vectors. 2017;10:197.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  12. 12.

    Benelli G, Jeffries CL, Walker T. Biological control of mosquito vectors: past, present, and future. Insects. 2016;7:52.

    PubMed Central  Article  PubMed  Google Scholar 

  13. 13.

    Marshall JM, White MT, Ghani AC, Schlein Y, Muller GC, Beier JC. Quantifying the mosquito’s sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control. Malar J. 2013;12:291.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Chaccour C, Barrio A, Gil Royo AG, Martinez Urbistondo D, Slater H, Hammann F, et al. Screening for an ivermectin slow-release formulation suitable for malaria vector control. Malar J. 2015;14:102.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  15. 15.

    Achee NL, Bangs MJ, Farlow R, Killeen F, Lindsay S, Logan JG, Moore SJ, et al. Spatial repellents from discovery and development to evidence-based validation. Malar J. 2012;11:164.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Bibbs CS, Kaufman PE. Volatile pyrethroids as a potential mosquito abatement tool: a review of pyrethroid-containing spatial repellents. J Integr Pest Manag. 2017;8:21.

    Article  Google Scholar 

  17. 17.

    Charlwood LM, Lawford H, Yeung S. Field assessment of a novel spatial repellent for malaria control: a feasibility and acceptability study in Mondulkiri, Cambodia. Malar J. 2017;16:412.

    PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Kawada H, Temu EA, Minjas J, Matsumoto O, Iwasaki T, Takagi M. Field evaluation of spatial repellency of metofluthrin-impregnated plastic strips against Anopheles gambiae complex in Bagamoyo, coastal Tanzania. JAMCA. 2008;24:404–9.

    Google Scholar 

  19. 19.

    Wagman JM, Grieco JP, Bautista K, Polanco J, Briceno I, King R, et al. The field evaluation of a push–pull system to control malaria vectors in northern Belize, Central America. Malar J. 2015;14:184.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    Syafruddin D, Asih PBS, Rozi IE, Permana DH, Nur Hidayati AP, Syahrani L, et al. Efficacy of a spatial repellent for control of malaria in indonesia: a cluster-randomized controlled trial. Am J Trop Med Hyg. 2020;103:344–58.

    PubMed  PubMed Central  Article  Google Scholar 

  21. 21.

    Ogoma SB, Ngonyani H, Simfukwe ET, Mseka A, Moore J, Maia MF, et al. The mode of action of spatial repellents and their impact on vectorial capacity of Anopheles gambiae sensu stricto. PLoS ONE. 2014;9:e110433.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  22. 22.

    Ogoma SB, Lorenz LM, Ngonyani H, Sangusangu R, Kitumbukile M, Kilalangongono M, et al. An experimental hut study to quantify the effect of DDT and airborne pyrethroids on entomological parameters of malaria transmission. Malar J. 2014;13:131.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  23. 23.

    Ten Bosch QA, Castro-Llanos F, Manda H, Morrison AC, Grieco JP, Achee NL, et al. Model-based analysis of experimental data from interconnected, row-configured huts elucidates multifaceted effects of a volatile chemical on Aedes aegypti mosquitoes. Parasites Vectors. 2018;11:365.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  24. 24.

    Zaim M, Aitio A, Nakashima N. Safety of pyrethroid-treated mosquito nets. Med Vet Entomol. 2000;14:1–5.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Mitchell SN, Stevenson BJ, Muller P, Wilding CS, Egyir-Yawson A, Field SG, et al. Identification and validation of a gene causing cross-resistance between insecticide classes in Anopheles gambiae from Ghana. Proc Natl Acad Sci USA. 2012;109:6147–52.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Norris EJ, Coats JR. Current and future repellent technologies: the potential of spatial repellents and their place in mosquito-borne disease control. Int J Environ Res Public Health. 2017;14:124.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  27. 27.

    Horstmann S, Sonneck R. Contact bioassays with phenoxybenzyl and tetrafluorobenzyl pyrethroids against target-site and metabolic resistant mosquitoes. PLoS ONE. 2016;11:e0149738.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  28. 28.

    Ferguson HM, Ng’habi KR, Walder T, Kadungula D, Moore SJ, Lyimo I, et al. Establishment of a large semi-field system for experimental study of African malaria vector ecology and control in Tanzania. Malar J. 2008;7:158.

    PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Okumu FO, Moore J, Mbeyela E, Sherlock M, Sangusangu R, Ligamba G, et al. A modified experimental hut design for studying responses of disease-transmitting mosquitoes to indoor interventions: the Ifakara experimental huts. PLoS ONE. 2012;7:e30967.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Stump AD, Atieli FK, Vulule JM, Besansky NJ. Dynamics of the pyrethroid knockdown resistance allele in western Kenyan populations of Anopheles gambiae in response to insecticide-treated bed net trials. Am J Trop Med Hyg. 2004;70:591–6.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Matowo NS, Munhenga G, Tanner M, Coetzee M, Feringa WF, Ngowo HS, et al. Fine-scale spatial and temporal heterogeneities in insecticide resistance profiles of the malaria vector, Anopheles arabiensis in rural south-eastern Tanzania. Wellcome Open Res. 2017;2:96.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    WHO. Test procedure for insecticides resistance monitoring in malaria vector mosquitoes. Geneva: World Health Organization; 2018.

  33. 33.

    Benedict MQ. The MR4 methods in Anopheles research laboratory manual. Atlanta: CDC; 2007. Accessed 10 Aug 2021.

  34. 34.

    Saddler A, Kreppel KS, Chitnis N, Smith TA, Denz A, Moore JD, et al. The development and evaluation of a self-marking unit to estimate malaria vector survival and dispersal distance. Malar J. 2019;18:441.

    PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Mmbando AS, Ngowo H, Limwagu A, Kilalangongono M, Kifungo K, Okumu FO. Eave ribbons treated with the spatial repellent, transfluthrin, can effectively protect against indoor-biting and outdoor-biting malaria mosquitoes. Malar J. 2018;17:368.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Mmbando AS, Batista EPA, Kilalangongono M, Finda MF, Mwanga EP, Kaindoa EW, et al. Evaluation of a push–pull system consisting of transfluthrin-treated eave ribbons and odour-baited traps for control of indoor- and outdoor-biting malaria vectors. Malar J. 2019;18:87.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    WHO. Specification and evaluations for public health pesticides, transfluthrin. Geneva: World Health Organization; 2006.

    Google Scholar 

  38. 38.

    Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67.

  39. 39.

    Abbott WS. A method for computing the effectiveness of an insecticide. J Econ Entomol. 1925;18:265–7.

    CAS  Article  Google Scholar 

  40. 40.

    Mmbando AS, Ngowo HS, Kilalangongono M, Abbas S, Matowo NS, Moore SJ, et al. Small-scale field evaluation of push–pull system against early- and outdoor-biting malaria mosquitoes in an area of high pyrethroid resistance in Tanzania. Wellcome Open Res. 2017;2:112.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  41. 41.

    Andrés M, Lorenz LM, Mbeleya E, Moore SJ. Modified mosquito landing boxes dispensing transfluthrin provide effective protection against Anopheles arabiensis mosquitoes under simulated outdoor conditions in a semi-field system. Malar J. 2015;14:255.

    PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Lwetoijera DW, Harris C, Dongus S, Devine GJ, McCall PJ, Majambere S. Increasing role of Anopheles funestus and Anopheles arabiensis in malaria transmission in the Kilombero Valley, Tanzania. Malar J. 2014;13:331.

    PubMed  PubMed Central  Article  Google Scholar 

  43. 43.

    Bohbot JD, Fu L, Le TC, Chauhan KR, Cantrell CL, Dickens JC. Multiple activities of insect repellents on odorant receptors in mosquitoes. Med Vet Entomol. 2011;25:436–44.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Spitzen J, Koelewijn T, Mukabana WR, Takken W. Visualization of house-entry behaviour of malaria mosquitoes. Malar J. 2016;15:233.

    PubMed  PubMed Central  Article  Google Scholar 

  45. 45.

    Katsuda Y, Leemingsawat S, Thongrungkiat S, Komalamisara N, Kanzaki T, Watanabe T, et al. Control of mosquito vectors of tropical infectious diseases. 1. Bioefficacy of mosquito coils containing several pyrethroids and a synergist. Southeast Asian J Trop Med Public Health. 2008;39:48–54.

    CAS  PubMed  Google Scholar 

  46. 46.

    Sukkanon C, Nararak J, Bangs MJ, Hii J, Chareonviriyaphap T. Behavioral responses to transfluthrin by Aedes aegypti, Anopheles minimus, Anopheles harrisoni, and Anopheles dirus (Diptera: Culicidae). PLoS ONE. 2020;15:e0237353.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  47. 47.

    Mongkalangoon P, Grieco JP, Achee NL, Suwonkerd W, Chareonviriyaphap T. Irritability and repellency of synthetic pyrethroids on an Aedes aegypti population from Thailand. J Vector Ecol. 2009;34:217–24.

    PubMed  Article  Google Scholar 

  48. 48.

    Gillies MT. Selection for host preference in Anopheles gambiae. Nature. 1964;203:852–4.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Curtis CF, Lines JD, Ijumba J, Callaghan A, Hill N, Karimzad MA. The relative efficacy of repellents against mosquito vectors of disease. Med Vet Entomol. 1987;1:109–19.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Mahande A, Mosha F, Mahande J, Kweka E. Feeding and resting behaviour of malaria vector, Anopheles arabiensis with reference to zooprophylaxis. Malar J. 2007;6:100.

    PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Asale A, Duchateau L, Devleesschauwer B, Huisman G, Yewhalaw D. Zooprophylaxis as a control strategy for malaria caused by the vector Anopheles arabiensis (Diptera: Culicidae): a systematic review. Infect Dis Poverty. 2017;6:160.

    PubMed  PubMed Central  Article  Google Scholar 

  52. 52.

    Iwashita H, Dida GO, Sonye GO, Sunahara T, Futami K, Njenga SM, et al. Push by a net, pull by a cow: can zooprophylaxis enhance the impact of insecticide treated bed nets on malaria control? Parasites Vectors. 2014;7:52.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  53. 53.

    Costantini C, Sagnon N, della Torre A, Coluzzi M. Mosquito behavioural aspects of vector-human interactions in the Anopheles gambiae complex. Parassitologia. 1999;41:209–17.

    CAS  PubMed  Google Scholar 

  54. 54.

    Potikasikorn J, Chareonviriyaphap T, Bangs MJ, Prabaripai A. Behavioral responses to DDT and pyrethroids between Anopheles minimus species A and C, malaria vectors in Thailand. Am J Trop Med Hyg. 2005;73:343–9.

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Van Roey K, Sokny M, Denis L, Van den Broeck N, Heng S, Siv S, et al. Field evaluation of picaridin repellents reveals differences in repellent sensitivity between Southeast Asian vectors of malaria and arboviruses. PLoS Negl Trop Dis. 2014;8:e3326.

    PubMed  PubMed Central  Article  Google Scholar 

  56. 56.

    Xue RD, Barnard DR. Human host avidity in Aedes albopictus: influence of mosquito body size, age, parity, and time of day. J Am Mosq Control Assoc. 1996;12:58–63.

    CAS  PubMed  Google Scholar 

  57. 57.

    Mulatier M, Porciani A, Nadalin L, Ahoua Alou LP, Chandre F, Pennetier C, et al. DEET efficacy increases with age in the vector mosquitoes Anopheles gambiae s.s. and Aedes albopictus (Diptera: Culicidae). J Med Entomol. 2018;55:1542–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  58. 58.

    Aldridge RL, Kaufman PE, Bloomquist JR, Gezan SA, Linthicum KJ. Application site and mosquito age influences malathion- and permethrin-induced mortality in Culex quinquefasciatus (Diptera: Culicidae). J Med Entomol. 2017;54:1692–8.

    CAS  PubMed  Article  Google Scholar 

  59. 59.

    Chadwick P. The activity of some pyrethroids, DDT and lindane in smoke from coils for biting inhibition, knockdown and kill of mosquitoes (Diptera, Culicidae). Bull Ent Res. 1975;65:97–107.

    CAS  Article  Google Scholar 

  60. 60.

    Sukkanon C, Bangs MJ, Nararak J, Hii J, Chareonviriyaphap T. Discriminating lethal concentrations for transfluthrin, a volatile pyrethroid compound for mosquito control in Thailand. J Am Mosq Control Assoc. 2019;35:258–66.

    PubMed  Article  Google Scholar 

Download references


Thanks to Bayer AG for generously donated the transfluthrin used in these experiments.


Ifakara Health Institute Vector Control Product Testing Unit (VCPTU) covered experimental costs. Salaries for Mgeni Tambwe, Sarah Moore and Adam Saddler were funded through a grant from the Innovative Vector Control Consortium (IVCC). IVCC would like to acknowledge that source funding for the ‘Push–Pull’ project came from the Bill & Melinda Gates Foundation and UK Aid.

Author information




SJM, AS and MMT conceived the study; AS and MMT performed the data collection; LH performed the molecular susceptibility assay for the An. arabiensis mosquitoes; AS, SJM, MMT and UAK performed data analysis; MMT wrote the manuscript; AS and SJM revised the manuscript. SJM and AS critically revised the final draft. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mgeni M. Tambwe.

Ethics declarations

Ethics approval and consent to participate

Permission to conduct these experiments was granted by ethical review committees at Ifakara Health Institute (IHI/IRB/No. 024-2016) and the National Institute for Medical Research (NIMR/HQ/R.8a/Vol.IX/2381). The volunteers participating in these experiments were IHI employees skilled in performing HLC. They were recruited voluntarily with written informed consent after the risks and benefits of the study procedures and their right to leave at any time during the study was clearly explained. All mosquitoes used in this experiment were laboratory-reared with low risk of transmitting malaria parasite.

Consent for publication

The Director General of NIMR granted the permission to publish this work.

Competing interests

The authors declare that they have no competing interests. SJM and UAK conduct contract product evaluation of a number of vector control tools.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Dataset for the evaluation of TG EPTI against Ifakara strain, Mbita strain and Kingani strain that support the conclusion of this article.

Additional file 2. 

Dataset for the evaluation of EC EPTI against Ifakara strain, Mbita strain and Kingani strain that support the conclusion of this article. 

Additional file 3.

Dataset for the evaluation of EC EPTI against Kisumu susceptible strain and Kisumu KDR strain that support the conclusion of this article.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tambwe, M.M., Moore, S., Hofer, L. et al. Transfluthrin eave-positioned targeted insecticide (EPTI) reduces human landing rate (HLR) of pyrethroid resistant and susceptible malaria vectors in a semi-field simulated peridomestic space. Malar J 20, 357 (2021).

Download citation


  • Volatile pyrethroid
  • Transfluthrin
  • Pyrethroid resistance
  • Eave-positioned targeted insecticide
  • EPTI
  • Anopheles gambiae
  • Anopheles arabiensis
  • Semi-field system